Finding 971139 (2023-001)

Significant Deficiency
Requirement
P
Questioned Costs
-
Year
2023
Accepted
2024-04-25

AI Summary

  • Answer: Management and the Board of Directors at HOPE, Inc. are responsible for ensuring the Data Collection Form (DCF) is submitted on time to the Federal Audit Clearinghouse (FAC).
  • Trend: Timely submission of the DCF is crucial for compliance and maintaining good standing with federal requirements.
  • List: Follow up on submission deadlines, monitor compliance processes, and ensure accountability within the management team.

Finding Text

Assignment of responsibility to management of HOPE, Inc. and Board of Directors that the Data Collection Form (DCF) is timely submitted to the Federal Audit Clearinghouse (FAC).

Categories

No categories assigned yet.

Other Findings in this Audit

  • 394691 2023-001
    Significant Deficiency
  • 394692 2023-001
    Significant Deficiency
  • 394693 2023-001
    Significant Deficiency
  • 394694 2023-001
    Significant Deficiency
  • 394695 2023-001
    Significant Deficiency
  • 394696 2023-001
    Significant Deficiency
  • 394697 2023-001
    Significant Deficiency
  • 394698 2023-001
    Significant Deficiency
  • 394699 2023-001
    Significant Deficiency
  • 394700 2023-001
    Significant Deficiency
  • 394701 2023-001
    Significant Deficiency
  • 394702 2023-001
    Significant Deficiency
  • 394703 2023-001
    Significant Deficiency
  • 394704 2023-001
    Significant Deficiency
  • 394705 2023-001
    Significant Deficiency
  • 394706 2023-001
    Significant Deficiency
  • 394707 2023-001
    Significant Deficiency
  • 394708 2023-001
    Significant Deficiency
  • 394709 2023-001
    Significant Deficiency
  • 971133 2023-001
    Significant Deficiency
  • 971134 2023-001
    Significant Deficiency
  • 971135 2023-001
    Significant Deficiency
  • 971136 2023-001
    Significant Deficiency
  • 971137 2023-001
    Significant Deficiency
  • 971138 2023-001
    Significant Deficiency
  • 971140 2023-001
    Significant Deficiency
  • 971141 2023-001
    Significant Deficiency
  • 971142 2023-001
    Significant Deficiency
  • 971143 2023-001
    Significant Deficiency
  • 971144 2023-001
    Significant Deficiency
  • 971145 2023-001
    Significant Deficiency
  • 971146 2023-001
    Significant Deficiency
  • 971147 2023-001
    Significant Deficiency
  • 971148 2023-001
    Significant Deficiency
  • 971149 2023-001
    Significant Deficiency
  • 971150 2023-001
    Significant Deficiency
  • 971151 2023-001
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
14.239 Home Investment Partnerships Program $297,941